Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

By Steve Porter LOVELAND Theres a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. Its called precision... Read More

By: Steve Porter Monday August 1, 2016 0 comments Tags: Loveland, NoCoBio Cluster, Innosphere, Deanna Scott, Chris Tompkins, Biodesix, Paul Beresford, KromaTid, Steven Schuster, UCHealth North, Alan Rudolph, Unsu Jung, MCR, Dana Stangel, Dr. Gary Luckasen

Biodesix: New clinical findings show diagnostic advances for novel drug

Biodesix: New clinical findings show diagnostic advances for novel drug

BOULDER -- Biodesix Inc . announced new clinical findings that show its novel investigational test, BDX008 based on profiling serum proteins identifies patients with advanced melanoma who are... Read More

Tuesday November 10, 2015 0 comments Tags: Boulder, Biodesix, Richard Hockett, melanoma, nivolumab

Amgen Foundation provides $25K grant to help launch CBSA teacher research program

Amgen Foundation provides $25K grant to help launch CBSA teacher research program

DENVER - Colorado BioScience Association (CBSA) announced the Amgen Foundation has provided a $25,000 grant to the Colorado BioScience Institute in support of the Research Experience for... Read More

By: InnovatioNews Tuesday July 22, 2014 0 comments Tags: Amgen Foundation, Anschutz Foundation, April Giles, Biodesix, CBSA, Denver, Surefire Medical

Biodesix closes on $20M debt financing with Capital Royalty Partners

Biodesix closes on $20M debt financing with Capital Royalty Partners

BOULDER - Biodesix Inc. , a fully-integrated molecular diagnostic company focused on personalized medicine, announced it has closed on a structured debt financing with Houston-based Capital... Read More

By: InnovatioNews Monday January 13, 2014 0 comments Tags: Biodesix, Boulder, Charles Tate, David Brunel, VeriStrat

CBSA: 2013 was successful year for state's bioscience sector

CBSA: 2013 was successful year for state's bioscience sector

DENVER - Colorado bioscience companies realized a number of key financings and acquisitions in 2013, according to the Colorado BioScience Association , an industry support group. "We saw... Read More

By: InnovatioNews Wednesday December 18, 2013 0 comments Tags: April Giles, Biodesix, Clovis Oncology, Denver, Gambro BCT, Inviragen, Lanx, SomaLogic, Surefire Medical